Quality of Life, Depression, and Anxiety in Patients Undergoing Renal Replacement Therapies in Saudi Arabia

Shdaifat, Emad

doi:10.1155/2022/7756586

Cited by 6 publications

(3 citation statements)

References 44 publications

(52 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This aligns with a systematic review's depression prevalence range (22.8% to 39.3%) [46]. In contrast, our study's anxiety prevalence was relatively lower than in Africa and Asia (40% to 61%) [7,40,47,48]. Variations in rates stem from factors like study populations, assessment methods, healthcare access, and cultural influences.…”

Section: Discussionsupporting

confidence: 83%

The Interplay of Anxiety, Depression, Sleep Quality, and Socioeconomic Factors in Somali Hemodialysis Patients

Kose,

Mohamed

2024

Brain Sciences

View full text Add to dashboard Cite

Objective: This study aimed to assess anxiety, depression, and sleep quality in kidney failure patients receiving hemodialysis (HD) in Somalia and examine the relationship between anxiety, depression, and sleep quality. Methods: We conducted a study with 200 kidney failure patients on HD treatment for over 3 months. Participants completed sociodemographic questionnaires, the Patient Health Questionnaire-9 (PHQ-9), the Hospital Anxiety and Depression Scale (HADS), the Insomnia Severity Index (ISI), and the Pittsburgh Sleep Quality Index (PSQI). Results: Among the 200 participants (mean age = 52.3; SD = 14.13), 58.5% were men, 64% had CKD for 1–5 years, and 52.6% received HD for 1–5 years. Depressive symptoms were found in 61.5% (PHQ-9) and 37.5% (HADS depression subscale) of HD patients. Poor sleep quality (PSQI) was observed in 31.5% and significantly correlated with PHQ-9 (rs = 0.633), HADS anxiety (rs = 0.491), and HADS depression (rs = 0.529). The ISI score correlated significantly with PHQ-9 (rs = 0.611), HADS anxiety (rs = 0.494), and HADS depression (rs = 0.586). All PSQI components correlated with depression and anxiety, except sleep medication use. Hierarchical regression analysis revealed that HADS anxiety (β = 0.342) and HADS depression (β = 0.372) predicted ISI scores. HADS anxiety (β = 0.307) and HADS depression (β = 0.419) predicted PSQI scores. Conclusions: Higher anxiety and depression levels negatively correlated with various dimensions of sleep quality in kidney failure patients. Early identification and appropriate management of these psychological disturbances are crucial for enhancing patients’ overall quality of life.

show abstract

Section: Discussionsupporting

confidence: 83%

The Interplay of Anxiety, Depression, Sleep Quality, and Socioeconomic Factors in Somali Hemodialysis Patients

Kose,

Mohamed

2024

Brain Sciences

View full text Add to dashboard Cite

show abstract

“…Recent reports [ 10 – 12 ] indicate that individuals with MHD may experience anxiety, depression, and other psychological distress, which can negatively affect up to 50% of these individuals and impact their overall quality of life [ 52 , 53 ]. It’s important for healthcare professionals to address these issues and provide necessary support and treatment to improve the mental well-being of MHD patients.…”

Section: Discussionmentioning

confidence: 99%

Effectiveness of psychoeducational interventions on psychological distress and health-related quality of life among patients with maintenance hemodialysis: a systematic review and meta-analysis

Zhang,

Zou,

Zhou

2024

Renal Failure

View full text Add to dashboard Cite

Objective To examine the effectiveness of psychoeducational interventions on depression, anxiety, and health-related quality of life (HRQOL) for people undergoing maintenance hemodialysis (MHD). Methods This review used systematic review and meta-analysis as the research design. Nine databases, including PubMed, Web of Science, Embase, CINAHL Complete, Cochrane Library, CNKI, WanFang, VIP, and Chinese Biomedical Literature Database, were searched from the inception to the 8th of July 2023. Two reviewers independently identified randomized controlled trials (RCT) examining the effects of psychoeducational interventions on MHD patients. Results Fourteen studies involving 1134 MHD patients were included in this review. The results of meta-analyses showed that psychoeducational intervention had significant short-term (< 1 m) (SMD: −0.87, 95% CI: −1.54 to −0.20, p = 0.01, I 2 = 91%; 481 participants), and medium-term (1–3 m) (SMD: −0.29, 95% CI: −0.50 to −0.08, p = 0.01, I 2 = 49%; 358 participants) on anxiety in MHD patients, but the effects could not be sustained at longer follow-ups. Psychoeducational interventions can also have short-term (< 1 m) (SMD: −0.65, 95% CI: −0.91 to −0.38, p < 0.00001, I 2 = 65%; 711 participants) and medium-term (1–3 m) (SMD: −0.42, 95% CI: −0.76 to −0.09, p = 0.01, I 2 = 69%; 489 participants) effects in reducing depression levels in MHD patients. Psychoeducational interventions that use coping strategies, goal setting, and relaxation techniques could enhance the QOL in MHD patients in the short term (< 1 m) (SMD: 0.86, 95% CI: 0.42 to 1.30, p = 0.02, I 2 = 86%; 241 participants). Conclusions Psychoeducational interventions have shown great potential to improve anxiety, depression, and quality of life in patients with MHD at the short- and medium-term follow-ups. Trial registration number: CRD42023440561.

show abstract

“…A significant question remains if depression improves after transplantation. Several authors reported that depression improved posttransplant or was less common posttransplant compared with pretransplant in heart and kidney recipients [23,27,40,46,50]. In liver recipients, however, two studies found that depression worsens after transplantation [43,51].…”

Section: Key Pointsmentioning

confidence: 99%

Depression in transplantation

Zimbrean¹

2022

Current Opinion in Organ Transplantation

View full text Add to dashboard Cite

Purpose of reviewTo review and summarize the literature published between 1 January 2020 and 30 June 2022, on the prevalence, risk factors and impact of depression in transplant population. Recent findingsDepression is common in transplantation candidates and recipients, with a prevalence up to 85.8% in kidney recipients. Multiple studies have indicated after transplantation depression correlates with increased mortality and with higher healthcare utilization. Social risk factors for posttransplant depression include financial difficulties and unemployment, while less is understood about the biological substrate of depression in this population. There is evidence that dynamic psychotherapy is effective for depression in organ transplant recipients, while cognitive behavioral therapy or supportive therapy did not lead to improvement of depression in transplant recipients. For living organ donors, the rates of depression are similar to the general population, with financial factors and the clinical status of the recipient playing a significant role. SummaryDepression is a common finding in transplant population. More research is needed to understand the biological substrate and risk factors and to develop effective treatment interventions.

show abstract

Quality of Life, Depression, and Anxiety in Patients Undergoing Renal Replacement Therapies in Saudi Arabia

Cited by 6 publications

References 44 publications

The Interplay of Anxiety, Depression, Sleep Quality, and Socioeconomic Factors in Somali Hemodialysis Patients

The Interplay of Anxiety, Depression, Sleep Quality, and Socioeconomic Factors in Somali Hemodialysis Patients

Effectiveness of psychoeducational interventions on psychological distress and health-related quality of life among patients with maintenance hemodialysis: a systematic review and meta-analysis

Depression in transplantation

Contact Info

Product

Resources

About